A study evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy (POSITIVE).

Study Chair
Dr. Olivia Pagani, Dr. Ann Partridge, Dr. Hatem Azim, Dr. Fedro Peccatori

Statistician
Samuel Niman

Lead Trial Coordinator
Holly Shaw

Trial Coordinator
Poonam Jani

Data Manager
Poonam Jani, Susan Fischer

Trial Monitors
Giuseppe Achille, Daniela Celotto, Carmen Comune, Magdalena Sánchez Hohl, Lionel Nobs, Mariana Pardo Contreras

IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 511 94 00
Fax: +41 31 511 94 01
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


Date of Activation in ROW
July 3, 2014

Targeted Accrual
518

International Breast
Cancer Study Group

Effingerstrasse 40
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: ibcsgcc@ibcsg.org

Member Login